Analysts foresee record year for Novozymes

For this year the company, located in revenue will be around 18.17 billion Danish Krone. This is according to the average of the analysts' estimates. The expected revenue would be a record for the company. This is slightly more than 2022's revenue of 17.55 billion Danish Krone.

Historical revenues and results Novozymes plus estimates 2023

beurskoers

The analysts expect for 2023 a net profit of 3.34 billion Danish Krone. For this year most of the analysts expect a profit per share of 11.81 Danish Krone. Based on this the price/earnings-ratio is 28.66.

For this year most of the analysts expect a dividend of 6 Danish Krone per share. Thus the dividend yield equals 1.77 percent. The average dividend yield of the chemical companies is an attractive 2.11 percent.

Based on the current number of outstanding shares Novozymes 's market capitalization is 75.61 billion Danish Krone.

Historical stock prices Novozymes from 2007 till 2023

financial analysis novozymes

At 13.53 the stock trades 0.62 percent higher at 338.5 Danish Krone.

Analist.nl Nieuwsdienst: +31 084-0032-842
nieuws@analist.nl

Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.